Steroid receptor coactivator 3 is required for clearing bacteria and repressing inflammatory response in Escherichia coli-induced septic peritonitis

Journal of Immunology

Volumn 185, Issue 9, 2010, Pages 5444-5452

  Chen, Qiang ^a,b   Chen, Tenghui ^a   Xu, Yixiang ^a   Zhu, Jingwei ^a   Jiang, Yuan ^a   Zhao, Yang ^a   Xu, Jianming ^c   Yu, Chundong ^a  

^a XIAMEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; PROTEIN BCL 2; SCAVENGER RECEPTOR A; STEROID RECEPTOR COACTIVATOR 3; CYTOKINE; NCOA3 PROTEIN, MOUSE;

APOPTOSIS; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CHROMATIN IMMUNOPRECIPITATION; ESCHERICHIA COLI INFECTION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; MOUSE MUTANT; PERITONITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS;

ANIMALS; APOPTOSIS; CHROMATIN IMMUNOPRECIPITATION; CYTOKINES; ESCHERICHIA COLI INFECTIONS; INFLAMMATION; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR COACTIVATOR 3; PERITONITIS; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; TRANSFECTION;

EID: 78149485502     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903802     Document Type: Article

References (53)

1. Angus, D. C., and R. S. Wax. 2001. Epidemiology of sepsis: an update. Crit. Care Med. 29 (7 Suppl): S109-S116.
2. van der Poll, T., and S. M. Opal. 2008. Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8:32-43.
3. van der Poll, T., and S. J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. North Am. 13:413-426.
4. Palladino, M. A., F. R. Bahjat, E. A. Theodorakis, and L. L. Moldawer. 2003. Anti-TNF-alpha therapies: the next generation. Nat. Rev. Drug Discov. 2:736-746.
5. Wheeler, A. P., and G. R. Bernard. 1999. Treating patients with severe sepsis. N. Engl. J. Med. 340:207-214.
6. Dalrymple, S. A., R. Slattery, D. M. Aud, M. Krishna, L. A. Lucian, and R. Murray. 1996. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect. Immun. 64:3231-3235.
7. Pinheiro da Silva, F., M. Aloulou, D. Skurnik, M. Benhamou, A. Andremont, I. T. Velasco, M. Chiamolera, J. S. Verbeek, P. Launay, and R. C. Monteiro. 2007. CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat. Med. 13:1368-1374.
8. Shuster, D. E., M. E. Kehrli, Jr., P. Rainard, and M. Paape. 1997. Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli. Infect. Immun. 65:3286-3292.
9. Anzick, S. L., J. Kononen, R. L. Walker, D. O. Azorsa, M. M. Tanner, X. Y. Guan, G. Sauter, O. P. Kallioniemi, J. M. Trent, and P. S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
10. Chen, H., R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalsky, Y. Nakatani, and R. M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
11. Torchia, J., D. W. Rose, J. Inostroza, Y. Kamei, S. Westin, C. K. Glass, and M. G. Rosenfeld. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684.
12. Li, H., P. J. Gomes, and J. D. Chen. 1997. RAC3, a steroid/nuclear receptorassociated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. USA 94:8479-8484.
13. Takeshita, A., G. R. Cardona, N. Koibuchi, C. S. Suen, and W. W. Chin. 1997. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272:27629-27634.
14. Zhou, G., Y. Hashimoto, I. Kwak, S. Y. Tsai, and M. J. Tsai. 2003. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol. Cell. Biol. 23:7742-7755.
15. Kuang, S. Q., L. Liao, S. Wang, D. Medina, B. W. O'Malley, and J. Xu. 2005. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res. 65:7993-8002.
16. Zhou, H. J., J. Yan, W. Luo, G. Ayala, S. H. Lin, H. Erdem, M. Ittmann, S. Y. Tsai, and M. J. Tsai. 2005. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 65:7976-7983.
17. Coste, A., M. C. Antal, S. Chan, P. Kastner, M. Mark, B. W. O'Malley, and J. Auwerx. 2006. Absence of the steroid receptor coactivator-3 induces B-cell lymphoma. EMBO J. 25:2453-2464.
18. Ying, H., M. C. Willingham, and S. Y. Cheng. 2008. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer. Oncogene 27:823-830.
19. Qin, L., L. Liao, A. Redmond, L. Young, Y. Yuan, H. Chen, B. W. O'Malley, and J. Xu. 2008. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol. Cell. Biol. 28:5937-5950.
20. Li, H. J., Z. Haque, Q. Lu, L. Li, R. Karas, and M. Mendelsohn. 2007. Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation. Proc. Natl. Acad. Sci. USA 104:4065-4070.
21. Coste, A., J. F. Louet, M. Lagouge, C. Lerin, M. C. Antal, H. Meziane, K. Schoonjans, P. Puigserver, B. W. O'Malley, and J. Auwerx. 2008. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 105:17187-17192.
22. Yu, C., B. York, S. Wang, Q. Feng, J. Xu, and B. W. O'Malley. 2007. An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response. Mol. Cell 25:765-778.
23. McClean, K. L., G. J. Sheehan, and G. K. Harding. 1994. Intraabdominal infection: a review. Clin. Infect. Dis. 19:100-116.
24. Xu, J., L. Liao, G. Ning, H. Yoshida-Komiya, C. Deng, and B. W. O'Malley. 2000. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. USA 97:6379-6384.
25. Saresella, M., K. Roda, L. Speciale, D. Taramelli, E. Mendozzi, F. Guerini, and P. Ferrante. 1997. A rapid evaluation of phagocytosis and killing of Candida albicans by CD13+ leukocytes. J. Immunol. Methods 210:227-234.
26. Tanaka, T., S. Akira, K. Yoshida, M. Umemoto, Y. Yoneda, N. Shirafuji, H. Fujiwara, S. Suematsu, N. Yoshida, and T. Kishimoto. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353-361.
27. Flo, T. H., K. D. Smith, S. Sato, D. J. Rodriguez, M. A. Holmes, R. K. Strong, S. Akira, and A. Aderem. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917-921.
28. Lai, X. H., J. G. Xu, S. Melgar, and B. E. Uhlin. 1999. An apoptotic response by J774 macrophage cells is common upon infection with diarrheagenic Escherichia coli. FEMS Microbiol. Lett. 172:29-34.
29. Woo, C. H., Y. W. Eom, M. H. Yoo, H. J. You, H. J. Han, W. K. Song, Y. J. Yoo, J. S. Chun, and J. H. Kim. 2000. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J. Biol. Chem. 275:32357-32362.
30. Sinha, A. K. 1972. Colorimetric assay of catalase. Anal. Biochem. 47:389-394.
31. Luo, D., and T. A. Rando. 2003. The regulation of catalase gene expression in mouse muscle cells is dependent on the CCAAT-binding factor NF-Y. Biochem. Biophys. Res. Commun. 303:609-618.
32. Wang, X., X. Meng, J. R. Kuhlman, L. D. Nelin, K. K. Nicol, B. K. English, and Y. Liu. 2007. Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria. J. Immunol. 178:5312-5320.
33. van Westerloo, D. J., I. A. Giebelen, S. Florquin, J. Daalhuisen, M. J. Bruno, A. F. de Vos, K. J. Tracey, and T. van der Poll. 2005. The cholinergic antiinflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 191:2138-2148.
34. Knapp, S., U. Matt, N. Leitinger, and T. van der Poll. 2007. Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J. Immunol. 178:993-1001.
35. Thomas, C. A., Y. Li, T. Kodama, H. Suzuki, S. C. Silverstein, and J. El Khoury. 2000. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J. Exp. Med. 191:147-156.
36. Kwiatkowska, K., and A. Sobota. 1999. Signaling pathways in phagocytosis. Bioessays 21:422-431.
37. Hilbi, H., Y. Chen, K. Thirumalai, and A. Zychlinsky. 1997. The interleukin 1betaconverting enzyme, caspase 1, is activated during Shigella flexneri-induced apoptosis in human monocyte-derived macrophages. Infect. Immun. 65:5165-5170.
38. Joseph, S. B., M. N. Bradley, A. Castrillo, K. W. Bruhn, P. A. Mak, L. Pei, J. Hogenesch, R. M. O'connell, G. Cheng, E. Saez, et al. 2004. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299-309.
39. Häcker, H., C. Fürmann, H. Wagner, and G. Häcker. 2002. Caspase-9/-3 activation and apoptosis are induced in mouse macrophages upon ingestion and digestion of Escherichia coli bacteria. J. Immunol. 169:3172-3179.
40. Albee, L., B. Shi, and H. Perlman. 2007. Aspartic protease and caspase 3/7 activation are central for macrophage apoptosis following infection with Escherichia coli. J. Leukoc. Biol. 81:229-237.
41. Wang, J. H., Y. J. Zhou, P. He, and B. Y. Chen. 2007. Roles of mitogen-activated protein kinase pathways during Escherichia coli-induced apoptosis in U937 cells. Apoptosis 12:375-385.
42. Kannan, K., and S. K. Jain. 2000. Oxidative stress and apoptosis. Pathophysiology 7:153-163.
43. Heim, W. G., D. Appleman, and H. T. Pyfrom. 1955. Production of catalase changes in animals with 3-amino-1, 2, 4-triazole. Science 122:693-694.
44. Hildeman, D. A., T. Mitchell, B. Aronow, S. Wojciechowski, J. Kappler, and P. Marrack. 2003. Control of Bcl-2 expression by reactive oxygen species. Proc. Natl. Acad. Sci. USA 100:15035-15040.
45. Li, D., E. Ueta, T. Kimura, T. Yamamoto, and T. Osaki. 2004. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci. 95:644-650.
46. Nenoi, M., S. Ichimura, K. Mita, O. Yukawa, and I. L. Cartwright. 2001. Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP100 cells. Cancer Res. 61:5885-5894.
47. Sewnath, M. E., D. P. Olszyna, R. Birjmohun, F. J. ten Kate, D. J. Gouma, and T. van der Poll. 2001. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J. Immunol. 166:6323-6331.
48. Peiser, L., P. J. Gough, T. Kodama, and S. Gordon. 2000. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun. 68:1953-1963.
49. Tapfer, H., A. Liigant, H. E. Simovart, E. Põldoja, K. Kokk, P. Naaber, and R. Talvik. 2003. Dissemination of bacteria in multiple organs associated with apoptosis and macrophage activity in different stages of experimental sepsis. Scand. J. Surg. 92:163-170.
50. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
51. Simon, H. U., A. Haj-Yehia, and F. Levi-Schaffer. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5:415-418.
52. Macdonald, J., H. F. Galley, and N. R. Webster. 2003. Oxidative stress and gene expression in sepsis. Br. J. Anaesth. 90:221-232.
53. Paterson, R. L., H. F. Galley, and N. R. Webster. 2003. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit. Care Med. 31:2574-2578.